CD8+ T cell‐mediated interface dermatitis during combination chemotherapy with mogamulizumab in a patient with adult T‐cell leukaemia/lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental dermatology 2018-08, Vol.43 (6), p.736-737
Hauptverfasser:	Tani, N., Sugita, K., Ito, A., Ooi, S., Yamamoto, O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Asian Continental Ancestry Group - ethnology CD8 antigen CD8-Positive T-Lymphocytes - drug effects CD8-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - pathology Chemotherapy Dermatitis Dermatitis - diagnosis Dermatitis - drug therapy Dermatitis - etiology Dermatitis - pathology Drug Eruptions - complications Drug Eruptions - diagnosis Drug Therapy, Combination Female Humans Immunotherapy Leukemia Leukemia-Lymphoma, Adult T-Cell - classification Leukemia-Lymphoma, Adult T-Cell - drug therapy Leukemia-Lymphoma, Adult T-Cell - pathology Lymph Nodes - pathology Lymphoma T-Lymphocytes - drug effects T-Lymphocytes - pathology Targeted cancer therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!